Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Overview of attention for article published in Clinical Breast Cancer, December 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 4 X users

reddit: 1 Redditor

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,237 followers.

RT @CBCjournal: Treatment of HER2-positive mBC is a substantial economic burden with HER2-targeted therapy accounting for 71-74% of mean an…

Treatment of HER2-positive mBC is a substantial economic burden with HER2-targeted therapy accounting for 71-74% of mean annual breast cancer-related cost. Read more 👇 #CBCjournal #bcsm @DrReshmaMahtani https://t.co/kQGQuAKJmz

New article: Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents https://t.co/oYXuWOmz0L #breastcancer #oncology https://t.co/0u7uFQIxOK

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.